SCHEMBL7359167

SCHEMBL7359167

O=C(O)/C=C/C(CCCCNC(=O)OCc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)N1CCOCC1

nearest known ligand 0.61

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CTSL P07711 10/20 0.61
CTSB P07858 4/20 0.55
TACR2 P21452 2/20 0.50
CTSS P25774 2/20 0.49
CTSH P09668 1/20 0.45
CTSK P43235 1/20 0.45
CTSC P53634 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7359183 1.00 CTSL (0.61) CTSLCTSBTACR2CTSSCTSH
SCHEMBL7359170 1.00 CTSL (0.61) CTSLCTSBTACR2CTSSCTSH
SCHEMBL7353053 0.89 CTSL (0.72) CTSLCTSBCTSSCTSHCTSK
SCHEMBL8492550 0.89 CTSL (0.72) CTSLCTSBCTSSCTSHCTSK
SCHEMBL7353049 0.89 CTSL (0.72) CTSLCTSBCTSSCTSHCTSK
SCHEMBL7351482 0.85 CTSL (0.54) CTSLCTSBTACR2CTSSCTSH
SCHEMBL7351491 0.85 CTSL (0.54) CTSLCTSBTACR2CTSSCTSH
SCHEMBL7351502 0.85 CTSL (0.54) CTSLCTSBTACR2CTSSCTSH
Bromide SCHEMBL7354476 0.84 CTSL (0.68) CTSLCTSBTACR2CTSSCTSH
Bromide SCHEMBL7361187 0.84 CTSL (0.68) CTSLCTSBTACR2CTSSCTSH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6287840-B1 PEPTIDOMIMETICS; COUPLING, DEBLOCKING; ANTIARTHRITIC, ANTITUMOR, ANTICARCINOGENIC, AND ANTIMETASTASIS AGENTS; MUSCULAR DYSTROPHY, GLOMERULONEPHRITIS, MALARIA, ALZHEIMER*S DISEASE AXYS PHARMACEUTICALS, INC. 2001-09-11 US disclosed
US-5976858-A (S)-(E)-3-(4-MORPHOLINE-CARBONYLLEUCYL)AMINO-5-PHENYL-1-PHENYL SULFONYL-1-PENTENE AND OTHERS; ANTIARTHRITIS/ANTITUMOR/ ANTIINFLAMMATORY/ANTIMETASTASIS AGENTS; TREATMENT OF MUSCULAR DYSTROPHY, MALARIA, ALZHEIMER'S AND AUTOIMMUNE DISEASES ARRIS PHARMACEUTICALS (US) 1999-11-02 US disclosed
WO-1995023222-A1 IRREVERSIBLE CYSTEINE PROTEASE INHIBITORS CONTAINING VINYL GROUPS CONJUGATED TO ELECTRON WITHDRAWING GROUPS KHEPRI PHARMACEUTICALS, INC. (US) 1995-08-31 WO disclosed